Specialist healthcare investor CBC Group has teamed up with APG Asset Management to launch a $1.5 billion fund dedicated to the development of healthcare infrastructure in China.
The fund, CBC China Life Science Infrastructure Venture, has reached a first close of $500 million. It will provide best-in-class life science research, manufacturing, and support services for biotechnology...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.